Project Mountain - Comparing SpO2 and SaO2 for Accuracy
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorPhilips Clinical & Medical Affairs Global
About this trial
The main goal of this study is to look at the performance of the neonatal, infant, and pediatric Philips SpO2 sensors with the Philips FAST Pulse Oximetry technology. Oxygen saturation measurements (SpO2) will be obtained via pulse oximetry and invasive arterial oxygen measurements (SaO2) will be obtained via arterial blood samples as part of your clinical care and assessed by co-oximetry. The study will aim to enroll a diverse population to help us understand the impact of skin pigmentation.
Eligibility criteria
Qualifiers
Subject aged 18 years or older or parent/legal guardian of subject aged less than 18 years, willing and able to understand and provide written informed consent/assent.
Weight and/or age within intended use of at least one SpO2 sensor under test at time of enrollment.
Willing and able to wear study devices in addition to SoC devices and during SoC procedures.
In-patient within a neonatal or pediatric intensive care unit (e.g. NICU, PICU, PCICU).
Disqualifiers
Known pregnancy or lactating females (self-reported)
Injury, wounds, physical malformation, hyperkeratosis, or compromised/non-intact skin at sensor application site (i.e. fingers, toes, hands, feet, ears, nasal ala). Note: Certain malformations may be allowed if determined it would not affect application of sensor with the pulse oximetry system.
Self-reported severe contact allergies to standard adhesives or other materials found in pulse oximetry sensors. Note: Subject may be considered eligible if subject can wear non-adhesive sensor.
Unwillingness or inability to remove nail polish or artificial nails from sensor application site.
Trial design
Treatments tested in this trial
- SaO2 Sampling
Treatment groups
560 Participants
are divided into 3 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov